Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Gamelin Erick. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 9 filings have been recorded. Activity tracked since 14 November 2022. The latest transaction was filed on 14 November 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
403 shares@ US$2.243.8% of flowCommon StockSEC:0000905148-25-004129:0
403 shares@ US$1.142.0% of flowCommon StockSEC:0000905148-25-001822:0
469 shares@ US$5.4211.9% of flowCommon StockSEC:0000905148-25-000727:0
402 shares@ US$7.9214.8% of flowCommon StockSEC:0000905148-24-003225:0
402 shares@ US$7.0212.6% of flowCommon StockSEC:0000905148-24-002279:0
402 shares@ US$8.3615.2% of flowCommon StockSEC:0000905148-24-001487:0
468 shares@ US$3.407.3% of flowCommon StockSEC:0000905148-24-000762:0
1,395 shares@ US$5.0832.4% of flowCommon StockSEC:0000905148-23-001474:0
20,030 shares0Common StockSEC:0001209191-22-057400:0